Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$23.14 - $34.72 $987,615 - $1.48 Million
42,680 New
42,680 $1.24 Million
Q3 2023

Nov 14, 2023

BUY
$37.8 - $45.97 $2.93 Million - $3.56 Million
77,477 New
77,477 $2.96 Million
Q3 2022

Nov 14, 2022

BUY
$42.28 - $57.17 $1.93 Million - $2.61 Million
45,701 New
45,701 $1.94 Million
Q2 2022

Aug 15, 2022

SELL
$53.86 - $66.52 $771,382 - $952,699
-14,322 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$62.86 - $69.24 $1.16 Million - $1.28 Million
-18,503 Reduced 56.37%
14,322 $920,000
Q4 2021

Feb 14, 2022

BUY
$62.47 - $73.25 $634,008 - $743,414
10,149 Added 44.76%
32,825 $2.2 Million
Q3 2021

Nov 15, 2021

BUY
$64.97 - $76.19 $1.47 Million - $1.73 Million
22,676 New
22,676 $1.55 Million
Q1 2021

May 17, 2021

SELL
$62.63 - $71.15 $2.01 Million - $2.28 Million
-32,109 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$43.31 - $66.55 $286,279 - $439,895
6,610 Added 25.92%
32,109 $2.09 Million
Q3 2020

Nov 16, 2020

BUY
$43.33 - $51.72 $738,083 - $880,998
17,034 Added 201.23%
25,499 $1.2 Million
Q2 2020

Aug 14, 2020

SELL
$41.42 - $55.57 $125,046 - $167,765
-3,019 Reduced 26.29%
8,465 $398,000
Q1 2020

May 15, 2020

BUY
$36.67 - $61.04 $421,118 - $700,983
11,484 New
11,484 $513,000
Q3 2019

Nov 14, 2019

SELL
$53.29 - $64.59 $683,763 - $828,754
-12,831 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$46.45 - $55.85 $46,357 - $55,738
998 Added 8.43%
12,831 $717,000
Q1 2019

May 15, 2019

BUY
$42.97 - $57.33 $175,188 - $233,734
4,077 Added 52.57%
11,833 $659,000
Q4 2018

Feb 14, 2019

SELL
$42.62 - $64.51 $195,497 - $295,907
-4,587 Reduced 37.16%
7,756 $350,000
Q3 2018

Nov 14, 2018

BUY
$57.63 - $65.87 $711,327 - $813,033
12,343 New
12,343 $813,000

Others Institutions Holding IART

About INTEGRA LIFESCIENCES HOLDINGS CORP


  • Ticker IART
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,518,200
  • Market Cap $2.18B
  • Description
  • Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...
More about IART
Track This Portfolio

Track Holocene Advisors, LP Portfolio

Follow Holocene Advisors, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on Holocene Advisors, LP with notifications on news.